【歌礼制药-B(01672.HK)专利遭石药挑战 公司称将全力捍卫】智通财经APP讯,歌礼制药-B(01672.HK)发

智通财经
30 Jun
【歌礼制药-B(01672.HK)专利遭石药挑战 公司称将全力捍卫】智通财经APP讯,歌礼制药-B(01672.HK)发布公告,该公司董事会于2025年6月24日获悉由石药集团有限公司(一家于香港联合交易所有限公司上市的公司,股份代号:1093)附属公司康久普乐生物医疗有限公司(Conjupro Biotherapeutics, Inc.)向美国专利商标局(USPTO)提交的一项复审。该复审质疑公司附属公司歌礼制药(中国)有限公司一项已获授权的美国专利(美国专利号:12,234,236)权利要求 1-9、12-17及21-25的有效性。截至本公告日期,该复审仍在USPTO审查中。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10